DR. MICHAEL BERELOWITZ, MD
Osteopathic Medicine at 37 St, New York, NY
License number
New York 163099
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
415 E 37Th St APT 36C, New York, NY 10016
Phone
(917) 690-3396
Organization information
See more information about MICHAEL BERELOWITZ at bizstanding.comMichael Berelowitz MD,MBBS
235 E 42 St, New York, NY 10017
Industry:
Internist
Phone:
(212) 573-2966 (Phone)
Michael Berelowitz
Michael Berelowitz MD
415 E 37 St, New York, NY 10016
Categories:
Endocrinology & Metabolism Physicians & Surgeons, Internal Medicine Physicians & Surgeons
Phone:
(212) 867-2323 (Phone)
Professional information
Medical Professional With Extensive Experience In Academia And Biopharmaceuticals
Position:
Adjunct Clinical Professor of Medicine, Division of Endocrinology at Mount Sinai School of Medicine
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
Mount Sinai School of Medicine
since Dec 2009
-
Adjunct Clinical Professor of Medicine, Division of Endocrinology
Pfizer
1996 - 2010
-
SVP, Clinical Development & Medical Affairs; Specialty Care
Stony Brook University School of Medicine
1985 - 1996
-
Professor Of Medicine; Head, Division of Endocrinology and Metabolism
Education:
University of Cape Town 1963 - 1968
MB ChB, Medicine American College of Physicians
FACP, Internal Medicine College Of Physicians
FCP(SA), Internal Medicine
MB ChB, Medicine American College of Physicians
FACP, Internal Medicine College Of Physicians
FCP(SA), Internal Medicine
Method Of Regulating Appetite And Metabolism
US Patent:
6013622, Jan 11, 2000
Filed:
Apr 15, 1998
Appl. No.:
9/060437
Inventors:
John F. Bruno - Centereach NY
Jeffrey White - Bridgewater NJ
Michael Berelowitz - New York NY
Daniel Tripodi - Lebanon NJ
Matthew Heil - Danbury CT
Jeffrey White - Bridgewater NJ
Michael Berelowitz - New York NY
Daniel Tripodi - Lebanon NJ
Matthew Heil - Danbury CT
Assignee:
Nutriceutical Technology Corporation - Bridgewater NJ
Research Foundation of State University of New York - Stony Brook NY
Research Foundation of State University of New York - Stony Brook NY
International Classification:
A61K 3100
US Classification:
514 2
Abstract:
Methods and compositions capable of controlling weight in an animal, preferably a human, which methods involve administering diet compositions that modulate, and preferably reduce, synthesis and secretion of neuropeptide Y (NPY) and modulate, and preferably increase synthesis and secretion of growth hormone releasing factor (GRF), compared to pre-administration amounts in the animal. The administration of such diet compositions results in a reduced appetite and a regulated metabolism that enhance weight control, including weight loss and reduction of obesity.